MAIT cells in circulation have been shown to express receptors for IP-10 (CXCR3) (63) and CCL22 (CCR4) (64), respectively, rendering them receptive to these chemokines, however, what this means for anti-tumor immunity is currently unclear. This evidence concerns the gene CXCR3 and neoplasm.